Tag: U.S. EPA

BioLargo expands government, water and AEC activity, but recurring revenue, lifecycle costs and funding needs remain central to its 2026 outlook.

BioLargo reports stronger AEC performance at Lake Stockholm as PFAS treatment, CupriDyne®, Aquatech, and Clyra shape its next commercial phase.